Ascendis Pharma
ASND
ASND
152 hedge funds and large institutions have $8.25B invested in Ascendis Pharma in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 79 increasing their positions, 40 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 12 → 12 (0)
5% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 20
1% less funds holding
Funds holding: 154 → 152 (-2)
Holders
152
Holding in Top 10
12
Calls
$37.5M
Puts
$10.6M
Top Buyers
| 1 | +$244M | |
| 2 | +$226M | |
| 3 | +$154M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$103M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$83.6M |
Top Sellers
| 1 | -$128M | |
| 2 | -$51.8M | |
| 3 | -$44.3M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$29.6M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$17.6M |